Related Experiment Video
Updated: Nov 13, 2025
09:01
Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
3.3K
Nanomaterials-Mediated Immunomodulation for Cancer Therapeutics
Ajita Jindal1, Sounik Sarkar2, Aftab Alam3,4,5
1School of Biotechnology, Jawaharlal Nehru University, New Delhi, India.
Frontiers in Chemistry
|March 12, 2021
Summary
Immunomodulatory nanomaterials (iNMs) offer novel cancer treatment strategies by harnessing the immune system. Understanding their complex interactions with the immune system is crucial for safe and effective clinical applications.
Area of Science:
- Oncology
- Immunology
- Nanotechnology
Background:
- Immunotherapy presents a promising alternative to conventional cancer treatments, with a growing focus on immune-based strategies.
- Nanotechnology has revolutionized cancer therapy, with nanomaterials (NMs) offering advantages like controlled drug delivery and enhanced stability.
- The interaction of NMs with the immune system is complex, potentially leading to adverse effects, necessitating a deeper understanding.
Purpose of the Study:
- To review recent advancements in immunomodulatory nanomaterials (iNMs) for cancer therapeutics.
- To elucidate the mechanisms underlying the interplay between NMs and the host immune system.
- To highlight the challenges and achievements in the clinical application of iNMs.
Main Methods:
- Literature review of recent developments in nanomedicine and cancer immunotherapy.
- Analysis of studies investigating the interaction between nanomaterials and immune cells.
- Synthesis of information on the immunomodulatory effects of various nanomaterials.
Main Results:
- Nanomaterials offer unique properties for cancer treatment, including targeted delivery and controlled release of therapeutic agents.
- The immune system's response to nanomaterials can be modulated, offering potential for enhanced anti-cancer immunity.
- Unintended immune reactions, such as inflammation and hypersensitivity, can occur, posing challenges for clinical translation.
Conclusions:
- Immunomodulatory nanomaterials represent a significant frontier in cancer therapy, leveraging the immune system for targeted cancer cell elimination.
- A comprehensive understanding of the nanomaterial-immune system interaction is essential for optimizing therapeutic efficacy and minimizing adverse events.
- Further research is needed to overcome challenges and ensure the safe and successful clinical application of iNMs in oncology.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
826
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
826
02:57Targeted Cancer Therapies
8.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.1K
01:27Cytotoxic T Cells-mediated Immune Response
6.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.0K
02:17The Tumor Microenvironment
7.2K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.2K
01:30Cancer Vaccines
617
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
617
02:49Cancer Therapies
9.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.0K